US · Healthcare

Cellectis S.A (CMVLF)

Biotechnology

Cellectis S.A (CMVLF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CMVLF

P/E ratio

25.00

Cellectis S.A (CMVLF) — FAQ

What is CMVLF's P/E ratio?

The price-to-earnings (P/E) ratio for Cellectis S.A (CMVLF) is 25.00 (data as of 2026-05-23).

Does Cellectis S.A pay a dividend?

Dividend yield is not available in the current snapshot for Cellectis S.A (CMVLF). Check the MyAverix Finance app for the latest dividend data.

What sector is Cellectis S.A in?

Cellectis S.A (CMVLF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is CMVLF listed on?

CMVLF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)